Avanos Medical (NYSE:AVNS) announced today that it appointed David Pacitti as its new CEO, effective April 14, 2025.
9h
MyChesCo on MSNOrchestra BioMed Reports 2024 Financial Results and Advances Cardiovascular TherapyNEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) has announced its financial results for 2024, alongside major ...
16d
TipRanks on MSNAvanos Medical Appoints David Pacitti as New CEOAn update from Avanos Medical ( ($AVNS) ) is now available. On March 17, 2025, Avanos Medical announced the appointment of David Pacitti as its ...
Avanos Medical named David Pacitti as its next chief executive officer, effective April 14. The medical technology company will pay Pacitti a base salary around $1.1 million and he would be eligible ...
ALPHARETTA, Ga., March 17, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS), a leading medical technology company, today announced the appointment of David Pacitti as its new chief executive ...
Avanos (AVNS) Medical announced the appointment of David Pacitti as its new CEO, effective April 14. Pacitti joins Avanos with a distinguished career in the healthcare sector, most recently ...
Related: Hospitals, medtech companies partner on devices to lower costs In an interview, David Pacitti, head of the Americas for Siemens Healthineers and president of Siemens Medical Solutions USA ...
(RTTNews) - Medical technology company Avanos Medical, Inc. (AVNS) announced Monday the appointment of David Pacitti as its new chief executive officer, effective April 14, 2025. Pacitti joins ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results